KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) FCF Margin (2016 - 2025)

Boston Scientific (BSX) has disclosed FCF Margin for 17 consecutive years, with 19.16% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 669.0% to 19.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18.22% through Dec 2025, up 243.0% year-over-year, with the annual reading at 18.22% for FY2025, 243.0% up from the prior year.
  • FCF Margin hit 19.16% in Q4 2025 for Boston Scientific, down from 22.94% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 25.85% in Q4 2024 to a low of 5.92% in Q1 2022.
  • Historically, FCF Margin has averaged 12.77% across 5 years, with a median of 14.36% in 2023.
  • Biggest five-year swings in FCF Margin: skyrocketed 1455bps in 2021 and later crashed -1351bps in 2022.
  • Year by year, FCF Margin stood at 6.78% in 2021, then surged by 171bps to 18.35% in 2022, then rose by 1bps to 18.52% in 2023, then soared by 40bps to 25.85% in 2024, then fell by -26bps to 19.16% in 2025.
  • Business Quant data shows FCF Margin for BSX at 19.16% in Q4 2025, 22.94% in Q3 2025, and 22.31% in Q2 2025.